Log in
0 followers
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.
Industries
Headquarters
Stage
Employees
Links
Thomas Cavanagh
7 members
4 members
3 members
Fios Genomics
3 followers
Sano Genetics
2 followers
evonetix
1 follower
Autolomous
BenevolentAI
6 followers
Discover companies